utritional education effect on metabolic syndrome in patients with spinal cord inury

Not Applicable

• Conditions: Condition 1: Metabolic Syndrom. Condition 2: Spinal Cord Injury.; Metabolic syndrome is a group of conditions that put you at risk for heart disease and diabetes. These conditions are high blood pressure high blood sugar levels high levels of triglycerides, a type of fat, in your blood low levels of hdl; Injuries to the spinal cord (S24.0 and S24.1) refer to the cord level and not bone level injury, and can affect nerve roots at and below the level given; E88.81

• Registration Number: IRCT201406215968N3
• Lead Sponsor: Brain and Spinal Injury Research Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

Inclusion criteria are : Age above 18; Minimum time since injury of 2 years ; Traumatic injury; BMI higher than 22. Exclusion criteria are: Pregnancy; lactation; Previous history of diseases that affect bone metabolism such as Paget’s disease; primary hyperparathyroidism; osteomalacia; Clinical hypocalcemia; hypophosphatemia; Consumption of medications like calcitonin, floride, calciteriol, heparin, phenytoin, phenobarbital and estrogen in the past 6 months; Consumption of bisphosphonates or corticosteroids for more than 6 months; previous history of consumption of methotrexate or floride; Recent consumption of medications (either synthetic or herbal) with anti-platelet activity, tetracyclin, magnesium or zinc supplements; Previous history of liver diseases or any symptoms indicating liver diseases based on screening laboratory tests; Previous history of fracture of femur or spine in the past year (unrelated to the trauma); Previous history of allergy to fish or fish oil; Anemia (confirmed by hemoglobin or hematocrit measurement); Hypertension

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cholesterol. Timepoint: At the baseline and then after 3 and 6 months. Method of measurement: Blood test.;Triglyceride. Timepoint: At the baseline and then after 3 and 6 months. Method of measurement: Blood test.;Low Density Lipoprotein (LDL). Timepoint: At the baseline and then after 3 and 6 months. Method of measurement: Blood test.;High Density Lipoprotein (HDL). Timepoint: At the baseline and then after 3 and 6 months. Method of measurement: Blood test.;Body Mass Index (BMI). Timepoint: At the baseline and then after 3 and 6 months. Method of measurement: Measring weight and height and calculation of BMI.;Waist circumstance. Timepoint: At the baseline and then after 3 and 6 months. Method of measurement: Direct measuremnet.;Fasting Blood Glucose. Timepoint: At the baseline and then after 3 and 6 months. Method of measurement: Blood test.